Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Encentuate was a specialized provider of identity and access management (IAM) solutions, with a significant focus on the healthcare sector. The company developed enterprise single sign-on (ESSO) and authentication management software designed to streamline clinician workflows while maintaining strict security and regulatory compliance. Its flagship platform, Encentuate TESS, allowed healthcare professionals to access multiple clinical applications and patient data systems with a single set of credentials or biometric authentication. This technology addressed critical needs in hospital settings for both data security and operational efficiency. In March 2008, Encentuate was acquired by IBM and integrated into its Tivoli software division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Encentuate.